BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6365797)

  • 1. Changes in circulating immune complexes in tumour patient serum after in vitro or ex vivo affinity chromatography of blood plasma or whole blood over immunoglobulin-binding staphylococcal protein A-Sepharose.
    Håkansson L; Hed J; Baldetorp L; Eneström S; Jonsson S; Liedén G
    Int J Artif Organs; 1984 Jan; 7(1):23-6. PubMed ID: 6365797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rapid and reproducible method for the analysis of immune complexes using affinity chromatography and Western blotting.
    Smith AJ; Cawston TE; Hazleman BL
    J Immunol Methods; 1985 Nov; 84(1-2):125-34. PubMed ID: 3877768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of immune-complex size and antigen-antibody ratio on immune complex detection with monoclonal rheumatoid factor and C1q.
    Vanham G; Bloemmen FJ; Ceuppens JL; Stevens EA
    J Clin Lab Immunol; 1984 Oct; 15(2):63-8. PubMed ID: 6335179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Circulating immune complexes: optimization and characteristics of the C1q(I125) fixation test].
    Caillot G; Lamelin JP; Hartmann DJ; Ville G
    Pathol Biol (Paris); 1984 Nov; 32(9):931-7. PubMed ID: 6334270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating immune complexes in the sera and ascites of hepatocellular carcinoma or chronic hepatitis patients.
    Chen YM; Hu CP; Wong FH; Chen PH; Tsai YT; Lee SD; Liu JD; Chang CM
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1986 Feb; 19(1):34-45. PubMed ID: 3028719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of a binding reactivity of human C-reactive protein for immunoglobulin or immune complexes.
    Ballou SP; Macintyre SS
    J Lab Clin Med; 1990 Mar; 115(3):332-8. PubMed ID: 2107267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes.
    Kilgallon W; Amlot PL; Williams BD
    Clin Exp Immunol; 1982 Jun; 48(3):705-14. PubMed ID: 6811171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-C1q affinity isolated circulating immune complexes correlate with extra-articular rheumatoid disease.
    Melsom RD; Horsfall AC; Schrieber L; Charles P; Maini RN
    Rheumatol Int; 1986; 6(5):227-31. PubMed ID: 3492027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and quantitation of circulating immune complexes by the C1q-protein A binding assay (C1q-PABA).
    Glikmann G; Svehag SE
    Methods Enzymol; 1981; 74 Pt C():571-88. PubMed ID: 6798369
    [No Abstract]   [Full Text] [Related]  

  • 10. Tumoricidal response following perfusion over immobilized protein A: identification of immunoglobulin oligomers in serum after perfusion and their partial characterization.
    Balint J; Ikeda Y; Langone JJ; Shearer WT; Daskal I; Meek K; Cook G; Henry J; Terman DS
    Cancer Res; 1984 Feb; 44(2):734-43. PubMed ID: 6607106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating immune complexes and rheumatoid arthritis.
    Faaber P; Rijke Schilder TP; Capel PJ; Koene RA
    J Rheumatol; 1985 Oct; 12(5):849-53. PubMed ID: 3878875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of circulating immune complexes in patients with squamous cell carcinoma of the oral cavity.
    Mukhopadhyaya R; Rao RS; Fakih AR; Gangal SG
    J Clin Lab Immunol; 1986 Dec; 21(4):189-93. PubMed ID: 3494132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of soluble immune complexes by affinity chromatography using staphylococcal protein A--Sepharose as substrate.
    Chenais F; Virella G; Patrick CC; Fudenberg HH
    J Immunol Methods; 1977; 18(1-2):183-92. PubMed ID: 915308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q.
    Nydegger UE; Lambert PH; Gerber H; Miescher PA
    J Clin Invest; 1974 Aug; 54(2):297-309. PubMed ID: 4847246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of immune complexes detectable by two independent assays in gynaecological malignancies.
    Poulton TA; Mooney NA; Nineham LJ; Hay FC
    Clin Exp Immunol; 1983 Sep; 53(3):573-80. PubMed ID: 6604605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical aspects of the 125I-C1q binding assay for detecting immune complexes in tumor patients.
    Krieger G; Bause I; Kneba M; Kehl A; Nagel GA
    J Clin Lab Immunol; 1984 Jun; 14(2):87-92. PubMed ID: 6611419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical aspects of immune complex assays employing polyethylene glycol.
    Cooper KM; Moore M
    J Immunol Methods; 1983 Jun; 60(3):289-303. PubMed ID: 6602185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential precipitation of the Clq subcomponent of the first complement component (C1) by polyethylene glycol from normal human serum and sera of patients with collagen diseases.
    Van Dijk H; Van Voorst J; Jankowski IG; Imhof JW; Kerckhaert JA
    Clin Exp Immunol; 1984 Aug; 57(2):495-501. PubMed ID: 6432386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of immune complexes by a microplate-adapted C1q-Protein A enzyme-linked-immunosorbent-assay (C1q-PA-ELISA).
    Bjerrum L; Glikmann G; Jensenius JC; Svehag SE
    J Clin Lab Immunol; 1983 Jan; 10(1):53-8. PubMed ID: 6338238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small albumin-immunoglobulin complexes in patients with liver disease.
    Zhen QY; Walther S; Sodomann CP
    Immunology; 1983 Apr; 48(4):809-16. PubMed ID: 6601051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.